Variant report
Variant | nsv967295 |
---|---|
Chromosome Location | chr4:63257265-63261479 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543412151 | chr4:63260430-63260431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542538300 | chr4:63260501-63260502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116830916 | chr4:63260542-63260543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139472651 | chr4:63260544-63260545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560725604 | chr4:63260629-63260630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556819228 | chr4:63260669-63260670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541123422 | chr4:63260683-63260684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114565988 | chr4:63260692-63260693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs374702357 | chr4:63260737-63260738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs561658669 | chr4:63260738-63260739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527868191 | chr4:63260739-63260740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs5858761 | chr4:63260744-63260745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs186287034 | chr4:63260753-63260754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76224277 | chr4:63260769-63260770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531904533 | chr4:63260811-63260812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549730649 | chr4:63260822-63260823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571627967 | chr4:63260843-63260844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35167504 | chr4:63260848-63260849 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs547868249 | chr4:63260849-63260850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs545245925 | chr4:63260871-63260872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566083681 | chr4:63260900-63260901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190748871 | chr4:63260979-63260980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1564224 | chr4:63260992-63260993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142769772 | chr4:63260999-63261000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537352659 | chr4:63261029-63261030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558220255 | chr4:63261063-63261064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576768762 | chr4:63261115-63261116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540709911 | chr4:63261130-63261131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553018488 | chr4:63261139-63261140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146091061 | chr4:63261157-63261158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs115771312 | chr4:63261175-63261176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs778945 | chr4:63261213-63261214 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs116345546 | chr4:63261253-63261254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148755240 | chr4:63261269-63261270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565488864 | chr4:63261285-63261286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532530020 | chr4:63261295-63261296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs182270062 | chr4:63261305-63261306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187685442 | chr4:63261369-63261370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530230903 | chr4:63261443-63261444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 20369283 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:63260400-63261000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr4:63260400-63261200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr4:63260800-63261200 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr4:63260800-63261200 | Enhancers | Primary hematopoietic stem cells | blood |
5 | chr4:63260800-63261200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr4:63261200-63263600 | Weak transcription | Primary hematopoietic stem cells | blood |